Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 440 record(s)

Req # A-2018-001694

All records pertaining to the creation, and any subsequent revisions, of the "Thinking about banking your child’s cord blood".

Organization: Health Canada

1070 page(s)
July 2023

Req # A-2019-001196

Regarding the safety review: "Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring Report a Concern Starting date: October 9, 2019. Posting date: October 9, 2019. The 10 incident reports, all the international reports an d all Health Canada committee notes and communications with Philips regarding this safety review.

Organization: Health Canada

280 page(s)
July 2023

Req # A-2020-000296

All records regarding the rationale for why the restriction on the sale of alkyl nitrites was implemented. Information regarding the evidence that is being drawn upon to support it, from Janaury 1, 2011 to June 1, 2020.

Organization: Health Canada

1698 page(s)
July 2023

Req # A-2020-001420

All communications sent/received by at officials the Director General (DG), Assitant Deputy Minister (ADM) or Deputy Minister (DM) level regarding the contract with BYD Canada Company Ltd.

Organization: Health Canada

19 page(s)
July 2023

Req # A-2021-000052

How many Canadian citizens in every province and terrirtory died specifically and only from Covid 19/Sars Cov2 without any other comorbities or health factors from August 2020 to March 2021. How many health effects or side effects from Canadian citizens for all provinces and territories from Covid 19/Sars Cov2 Vaccines, have been reported to Health Canada from January 2021 to March 2021. What health effects or side effects were reported to Health Canada from all Canadian citizens, from all provinces and territories, for all Covid 19/Sars Cov2 Vaccines given to Canadian citizens from January 2021 to March 2021.

Organization: Health Canada

117 page(s)
July 2023

Req # A-2021-000869

Copy of all correspondence relating to complaints received regarding Computerixed Tomography (CT) Scans from January 2009 to August 25, 2021.

Organization: Health Canada

270 page(s)
July 2023

Req # A-2021-001621

Information about the Indigenous Navigator program that was stood up by Health Canada to enhance the services available to Indigenous applicants for cannabis licenses. Dates of interest would be 2017 to December 21, 2021.

Organization: Health Canada

286 page(s)
July 2023

Req # A-2022-000397

Any records the Registrant submitted in relation to the following applications: 2022-1039 (Reg. No. 21273), 2022-1040 (Reg. No. 21247) and 2022-1041 (Reg. No. 33125); any records provided by Health Canada and/or the Pest Management Regulatory Agency of Canada submitted in relation to the three applications listed above, namely: 2022-1039 (Reg. No. 21273), 2022-1040 (Reg. No. 21247) and 2022-1041 (Reg. No. 33125).

Organization: Health Canada

32 page(s)
July 2023

Req # A-2022-000450

Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate. The dosage form, and in particular whether the dosage form is either a tablet or an orally disintegrating tablet, in which it is proposed that the new drug in the Desmopressin ANDS be sold, as described in paragraph C.08.002(2)(l) of the Food and Drug Regulations.

Organization: Health Canada

3 page(s)
July 2023

Req # A-2022-000451

Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate. Provide the name of the company who submitted the Desmopressin ANDS, which was accepted into review on or after March 1, 2022.

Organization: Health Canada

3 page(s)
July 2023
Date modified: